irdabisant (CEP-26401) / Teva  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
irdabisant (CEP-26401) / Teva
NCT01903824: Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects

Completed
1
40
Europe
CEP-26401, Irdabisant, donepezil hydrochloride, Aricept, modafinil, Provigil, Placebo
Teva Branded Pharmaceutical Products R&D, Inc.
Cognitive Impairment
10/13
12/13

Download Options